Back to search
FDAFDA · Food and drugs·Recall number D-0215-2017

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA

Published December 28, 2016 · Recall initiated: August 19, 2016

Summary

FDA records drug Class I recall D-0215-2017, published December 28, 2016 and initiated August 19, 2016. Recalling firm: Impax Laboratories, Inc.; Status: Terminated; Reported quantity: 3,074 boxes (30 count boxes); Lot: Lot Number 502240, expiry date 11/2017. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Impax Laboratories, Inc.
Distributor
Distributed Nationwide
Lot
Lot Number 502240, expiry date 11/2017
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA recalled?

Yes. FDA published recall D-0215-2017 on December 28, 2016. Reported hazard: Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

What should I do if I have this product?

Voluntary: Firm initiated · Letter